|
ECLIPSE 3
Welcome & Introduction - Dr. Paul Lacante (BMS Medical Director) |
Mode of Action video dual IO |
Dual IO: experience in MESOTHELIOMA - case study (20') plus Q&A (5') - Prof. Dr. Paul Baas |
Dual IO: experience in NSCLC - case study (20') plus Q&A (5') - Prof. Dr. Luis Paz-Ares |
Meet the Expert: Panel discussion |
Meeting close |

ONC-BE-2100170
Start moduleONC-BE-2100170
S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.
Start moduleONC-BE-2100170
Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.
Start moduleONC-BE-2100170
Start moduleONC-BE-2100170

ONC-BE-2100170
Start moduleONC-BE-2100170
S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.
Start moduleONC-BE-2100170
Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.
Start moduleONC-BE-2100170
Start module